Physicians

Department / Division
Medicine / Medicine - Hematology

Address
DUMC 3422
Durham, NC 27710

Appointment Telephone
919-660-4363

Office Telephone
919-684-5350

Fax Telephone
919-681-6160

Training

• MD, MCP, Hahnemann (Drexel University College of Medicine, Pennsylvania), 2001

Residency

• Internal Medicine, UNC Hospitals, 2004

Fellowship

• Hematology-Oncology, Hospital of the University of Pennsylvania, 2008
• Hematology-Oncology, Duke University Medical Center, 2008

Clinical Interests
Disorders of hemostasis and thrombosis, red cell and platelet disorders

Industry Relationships and Collaborations (What's this?)

This faculty member has no reported relationships with industry.

Representative Publications
Metjian, A; Abrams, CS. New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents. Biologics: Targets and Therapy. 2009;3:499-513. (2009) Abstract

Metjian, A; Lim, W. ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2009;247-249. (2009) Abstract

Metjian, A; Abrams, CS. New insights and therapeutics for immune-mediated thrombocytopenia. Expert Review of Cardiovascular Therapy. 2008;6:71-84. (2008) Abstract

Metjian, A; Roll, RL; Ma, AD; Abrams, CS. Agonists cause nuclear translocation of phosphatidylinositol 3-kinase gamma. A Gbetagamma-dependent pathway that requires the p110gamma amino terminus. Journal of Biological Chemistry. 1999;274:27943-27947. (1999) Abstract

Ma, AD; Metjian, A; Bagrodia, S; Taylor, S; Abrams, CS. Cytoskeletal reorganization by G protein-coupled receptors is dependent on phosphoinositide 3-kinase gamma, a Rac guanosine exchange factor, and Rac. Molecular and Cellular Biology. 1998;18:4744-4751. (1998) Abstract